Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001070677 | SCV001235942 | likely benign | Epilepsy, familial adult myoclonic, 5 | 2024-01-08 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004030760 | SCV003946209 | uncertain significance | not specified | 2023-05-03 | criteria provided, single submitter | clinical testing | The c.3001G>A (p.V1001M) alteration is located in exon 22 (coding exon 21) of the CNTN2 gene. This alteration results from a G to A substitution at nucleotide position 3001, causing the valine (V) at amino acid position 1001 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |